U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Armada Nutrition - 03/13/2018
  1. Warning Letters

CLOSEOUT LETTER

Armada Nutrition

Recipient:
Armada Nutrition

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

 
 
Cincinnati District Office
6751 Steger Drive
Cincinnati, OH 45237
Telephone: (513) 679-2700
FAX: (513) 679-2772 

VIA Email

March 13, 2018

Mr. Brent A. Laffey, President
Armada Nutrition, LLC
4637 Port Royal Rd.
Spring Hill, TN 37174-2834

The Food and Drug Administration (FDA) has completed an evaluation of your firm 's corrective actions in response to our Warning Letter 523876 dated August 1, 2017. Based on our evaluation, it appears that you have addressed the violations and/or deviations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The FDA expects you and your firm to maintain compliance with current good manufacturing practices and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations and/or deviations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Stephen J. Rabe
Compliance Officer 

Back to Top